Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ricky-Ruiqi Zhang"'
Autor:
Kun Wen, Jian-Piao Cai, Xiaodi Fan, Xiaojuan Zhang, Cuiting Luo, Kai-Ming Tang, Huiping Shuai, Lin-Lei Chen, Ricky Ruiqi Zhang, Jianwen Situ, Hoi-Wah Tsoi, Kun Wang, Jasper Fuk-Woo Chan, Shuofeng Yuan, Kwok-Yung Yuen, Hongwei Zhou, Kelvin Kai-Wang To
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
IntroductionTherapeutic monoclonal antibodies (mAbs) against the SARS-CoV-2 spike protein have been shown to improve the outcome of severe COVID-19 patients in clinical trials. However, novel variants with spike protein mutations can render many curr
Externí odkaz:
https://doaj.org/article/398b30d745284da3b330a347ae0d45fd
Autor:
Lu Lu, Allen Wing-Ho Chu, Ricky Ruiqi Zhang, Wan-Mui Chan, Jonathan Daniel Ip, Hoi-Wah Tsoi, Lin-lei Chen, Jian-Piao Cai, David Christopher Lung, Anthony Raymond Tam, Yat-Sun Yau, Mike Yat-Wah Kwan, Wing-Kin To, Owen Tak-Yin Tsang, Larry Lap-Yip Lee, Haisu Yi, Tak-Chuen Ip, Rosana Wing-Shan Poon, Gilman Kit-Hang Siu, Bobo Wing-Yee Mok, Vincent Chi-Chung Cheng, Kwok Hung Chan, Kwok-Yung Yuen, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To
Publikováno v:
EBioMedicine, Vol 71, Iss , Pp 103544- (2021)
Background: Several SARS-CoV-2 lineages with spike receptor binding domain (RBD) N501Y mutation have spread globally. We evaluated the impact of N501Y on neutralizing activity of COVID-19 convalescent sera and on anti-RBD IgG assays. Methods: The sus
Externí odkaz:
https://doaj.org/article/92bebd560c144436b481681070d02e46
Autor:
Athene Hoi-Ying Lam, Jian-Piao Cai, Ka-Yi Leung, Ricky-Ruiqi Zhang, Danlei Liu, Yujing Fan, Anthony Raymond Tam, Vincent Chi-Chung Cheng, Kelvin Kai-Wang To, Kwok-Yung Yuen, Ivan Fan-Ngai Hung, Kwok-Hung Chan
Publikováno v:
Diagnostics, Vol 11, Iss 12, p 2346 (2021)
Immunofluorescence is a traditional diagnostic method for respiratory viruses, allowing rapid, simple and accurate diagnosis, with specific benefits of direct visualization of antigens-of-interest and quality assessment. This study aims to evaluate t
Externí odkaz:
https://doaj.org/article/d520f2dd581146d68426fc47e05ff2c9
Autor:
Kwok-Hung Chan, Ka-Yi Leung, Ricky-Ruiqi Zhang, Danlei Liu, Yujing Fan, Honglin Chen, Kwok-Yung Yuen, Ivan Fan-Ngai Hung
Publikováno v:
Diagnostics, Vol 11, Iss 10, p 1757 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibody (NAb) production is a crucial humoral response that can reduce re-infection or breakthrough infection. The conventional test used to measure NAb production capacity le
Externí odkaz:
https://doaj.org/article/101a3f496e4342aea0291d77972cee10
Autor:
Anthony Raymond Tam, Ricky Ruiqi Zhang, Kwok-Cheung Lung, Raymond Liu, Ka-Yi Leung, Danlei Liu, Yujing Fan, Lu Lu, Athene Hoi-Ying Lam, Tom Wai-Hin Chung, Cyril Chik-Yan Yip, Jenny Lo, Alan Ka-Lun Wu, Rodney Lee, Simon Sin, Pauline Yeung Ng, Wai-Ming Chan, Hoi-Ping Shum, Wing-Wa Yan, Jasper Fuk-Woo Chan, Vincent Chi-Chung Cheng, Chak-Sing Lau, Kelvin Kai-Wang To, Kwok-Hung Chan, Kwok-Yung Yuen, Ivan Fan-Ngai Hung
Publikováno v:
Clinical Infectious Diseases. 76:e216-e226
Background Early antiviral therapy was effective in the treatment of coronavirus disease 2019 (COVID-19). We assessed the efficacy and safety of combined interferon beta-1b and remdesivir treatment in hospitalized COVID-19 patients. Methods We conduc
Autor:
Tak-Lun Que, Jonathan Daniel Ip, Charlotte Yee Ki Choi, Kwok-Yung Yuen, Hoi-Wah Tsoi, Kelvin K. W. To, Allen Wing-Ho Chu, Ivan Hung, Anthony Raymond Tam, Ricky Ruiqi Zhang, Cyril C. Y. Yip, Wing-Kin To, Vincent C.C. Cheng, Daphne Pui-Ling Lau, Xiaojuan Zhang, Lu Lu, Wan-Mui Chan, Jian-Piao Cai, Lin-Lei Chen, Kwok-Hung Chan
Publikováno v:
Clinical Infectious Diseases. 74:1623-1630
Background Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages with mutations at the spike protein receptor binding domain (RBD) have reduced susceptibility to antibody neutralization, and have been classified as variants of
Autor:
SL Lui, Efrat Kochba, Kwok-Hung Chan, Man-Fung Yuen, Johnson Y.N. Lau, Desmond Y H Yap, Ricky Ruiqi Zhang, Yotam Levin, Kwok-Yung Yuen, Tak Mao Chan, Ivan Hung, Kelvin K. W. To, Terence P.S. Yip, Sydney C.W. Tang
Publikováno v:
Clinical Infectious Diseases. 73:e304-e311
Background Patients on dialysis are hyporesponsive to the hepatitis B virus vaccines (HBVv). We examined intradermal (ID) HBVv Sci-B-Vac, with topical Toll-like receptor 7 (TLR7) agonist imiquimod pretreatment in dialysis patients. Methods We enrolle
Autor:
Anthony Raymond, Tam, Ricky Ruiqi, Zhang, Kwok Cheung, Lung, Raymond, Liu, Ka Yi, Leung, Danlei, Liu, Yujing, Fan, Lu, Lu, Athene Hoi Ying, Lam, Tom Wai Hin, Chung, Cyril Chik Yan, Yip, Jenny, Lo, Alan Ka Lun, Wu, Rodney, Lee, Simon, Sin, Pauline Yeung, Ng, Wai Ming, Chan, Hoi Ping, Shum, Wing Wa, Yan, Jasper Fuk Woo, Chan, Vincent Chi Chung, Cheng, Chak Sing, Lau, Kelvin, Kai-Wang, Kwok Hung, Chan, Kwok Yung, Yuen, Ivan Fan Ngai, Hung
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Early antiviral therapy was effective in the treatment of COVID-19. We assessed the efficacy and safety of combined interferon beta-1b and remdesivir treatment in hospitalized COVID-19 patients.We conducted a multicentre, prospective open-label, rand
Autor:
Chun-Ka Wong, Yee-Man Lau, Wing-Hon Lai, Ricky-Ruiqi Zhang, Hayes Kam-Hei Luk, Antonio Cheuk-Pui Wong, Patrick Chiu-Yat Woo, Susanna Kar-Pui Lau, Kwok-Hung Chan, Ivan Fan-Ngai Hung, Chung-Wah Siu
Publikováno v:
Cardiology journal. 29(4)
Autor:
Kelvin K. W. To, Bobo Wing-Yee Mok, Ivan Hung, Hoi-Wah Tsoi, Wing-Kin To, Vincent C.C. Cheng, David Christopher Lung, Jonathan Daniel Ip, Yat-Sun Yau, Anthony Raymond Tam, Lu Lu, Wan-Mui Chan, Lin-Lei Chen, Ricky Ruiqi Zhang, Tak-Chuen Ip, Gilman Kit Hang Siu, Kwok-Hung Chan, Larry Lap-Yip Lee, Jian-Piao Cai, Rosana W.S. Poon, Mike Yat-Wah Kwan, Owen Tak-Yin Tsang, Haisu Yi, Kwok-Yung Yuen, Allen Wing-Ho Chu
Publikováno v:
EBioMedicine, Vol 71, Iss, Pp 103544-(2021)
EBioMedicine
EBioMedicine
BACKGROUND: Several SARS-CoV-2 lineages with spike receptor binding domain (RBD) N501Y mutation have spread globally. We evaluated the impact of N501Y on neutralizing activity of COVID-19 convalescent sera and on anti-RBD IgG assays. METHODS: The sus